REVANCE THERAPEUTICS INC (RVNC)

US7613301099 - Common Stock

3.4  +0.11 (+3.34%)

After market: 3.4 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
234.04M132.60M77.80M15.30M400.00K
Cost Of Goods
74.36M51.70M23.40M4.80MN/A
Gross Profit
159.68M80.90M54.40M10.60MN/A
Operating Expenses
380.40M353.00M329.10M283.70M164.90M
Research and Development
74.47M99.60M114.50M123.70M102.90M
Selling, General, and Administrative Expenses
292.24M217.10M192.10M149.70M62.00M
Operating Income
-220.72M-272.20M-274.70M-273.20M-164.50M
Interest Income/Expense
-6.07M-11.60M-5.90M-11.00M5.30M
Other Income/Expense
-838.00K-2.20M-800.00K-600.00K-300.00K
Non Recurring Items
-96.05M-69.80MN/AN/A0.00
Income Before Taxes
-323.69M-355.70M-281.30M-284.70M-159.40M
Income Tax
300.00K700.00K0.00-2.60M0.00
Net Income
-323.99M-356.40M-281.30M-282.10M-159.40M
EBITDA
-209.35M-238.47M-254.85M-262.95M-161.59M
 
Per Share Data
EPS Diluted Total Ops
-3.83-4.90-4.17-4.86-3.67
Non GAAP EPS
-3.79-3.94-4.18-4.83-3.66
 
Statistics
Gross Profit Margin
68.23%61.01%69.92%69.28%N/A
Profit Margin
-138.43%-268.78%-361.57%-1843.79%-39850.00%
Operating Profit Margin
-94.31%-205.28%-353.08%-1785.62%-41125.00%

All data in USD

Charts